Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining

Figure 1

The distinct upregulation of MATN3 and its association with clinical features. (a) MATN3 expression was determined in GC specimens and non-tumor specimens using TCGA datasets. MATN3 mRNA levels were classified by age (b), sex (c), cancer status(d), stage(e), and grade(f).

(a)

(b)

(c)

(d)

(e)

(f)